Domača stranVBIVQ • OTCMKTS
add
VBI Vaccines Inc
Prejšnji trg. dan.
0,00050 $
Dnevni razpon
0,00050 $ - 0,00060 $
Letni razpon
0,00020 $ - 0,051 $
Tržna kapitalizacija
7,17 tis. USD
Povprečni obseg
56,23 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
OTCMKTS
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 1,21 mio. | 150,31 % |
Stroški poslovanja | 10,24 mio. | −37,68 % |
Čisti dohodek | −17,90 mio. | 35,50 % |
Čista dobičkovnost prihodkov | −1,47 tis. | 74,23 % |
Earnings per share | — | — |
EBITDA | −11,26 mio. | 40,75 % |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 12,60 mio. | −68,82 % |
Skupna sredstva | 75,44 mio. | −41,27 % |
Skupne obveznosti | 80,91 mio. | −3,03 % |
Celoten lastniški kapital | −5,47 mio. | — |
Shares outstanding | 28,68 mio. | — |
Razmerje P/B | −0,00 | — |
Donosnost sredstev | −36,18 % | — |
Donosnost kapitala | −55,53 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −17,90 mio. | 35,50 % |
Denar iz dejavnosti | −11,77 mio. | 45,65 % |
Denar iz naložb | −151,00 tis. | 71,72 % |
Denar iz financiranja | 843,00 tis. | — |
Neto sprememba denarnih sredstev | −11,09 mio. | 50,13 % |
Prost denarni tok | −4,40 mio. | 70,09 % |
Vizitka
Variation Biotechnologies Inc., also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty researchers working with National Research Council of Canada to produce a COVID-19 vaccine—VBI-2902. In August VBI received CA$56 million from the Government of Canada to prepare its vaccine for clinical trials by the end of 2020. The company's CEO, Jeff Baxter, said that VBI-2902 is cheaper to produce than other vaccines. Wikipedia
Datum ustanovitve
1965
Spletno mesto
Zaposleni
135
